期刊
ONCOGENE
卷 35, 期 10, 页码 1261-1270出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2015.180
关键词
-
资金
- Enterprise Ireland
- National Development Plan of Ireland
- Commercialisation Fund [CFTD/06/112]
- SFI SIRG award [09/SIRG/B1575]
- NUIG
- Science Foundation Ireland (SFI) [09/SIRG/B1575] Funding Source: Science Foundation Ireland (SFI)
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a death ligand cytokine known for its cytotoxic activity against malignantly transformed cells. TRAIL induces cell death through binding to death receptors DR4 and DR5. The inhibitory decoy receptors (DcR1 and DcR2) co-expressed with death receptor 4 (DR4)/DR5 on the same cell can block the transmission of the apoptotic signal. Here, we show that DcRs also regulate TRAIL sensitivity at a supracellular level and thus represent a mechanism by which the microenvironment can diminish tumour TRAIL sensitivity. Mathematical modelling and layered or spheroid stroma-extracellular matrix-tumour cultures were used to model the tumour microenvironment. By engineering TRAIL to escape binding by DcRs, we found that DcRs do not only act in a cell-autonomous or cis-regulatory manner, but also exert trans-cellular regulation originating from stromal cells and affect tumour cells, highlighting the potent inhibitory effect of DcRs in the tumour tissue and the necessity of selective targeting of the two death-inducing TRAIL receptors to maximise efficacy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据